These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34725457)

  • 1. Metabolic profiling of attached and detached metformin and 2-deoxy-D-glucose treated breast cancer cells reveals adaptive changes in metabolome of detached cells.
    Repas J; Zügner E; Gole B; Bizjak M; Potočnik U; Magnes C; Pavlin M
    Sci Rep; 2021 Nov; 11(1):21354. PubMed ID: 34725457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-treatment of breast cancer cells with pharmacologic doses of 2-deoxy-D-glucose and metformin: Starving tumors.
    Wokoun U; Hellriegel M; Emons G; Gründker C
    Oncol Rep; 2017 Apr; 37(4):2418-2424. PubMed ID: 28350075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro.
    Bizjak M; Malavašič P; Dolinar K; Pohar J; Pirkmajer S; Pavlin M
    Sci Rep; 2017 May; 7(1):1761. PubMed ID: 28496098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer Cells.
    Repas J; Zupin M; Vodlan M; Veranič P; Gole B; Potočnik U; Pavlin M
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy.
    Samuel SM; Varghese E; Satheesh NJ; Triggle CR; Büsselberg D
    Biomed Pharmacother; 2023 Aug; 164():114911. PubMed ID: 37224753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Glucose Represses the Anti-Proliferative and Pro-Apoptotic Effect of Metformin in Triple Negative Breast Cancer Cells.
    Varghese S; Samuel SM; Varghese E; Kubatka P; Büsselberg D
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30626087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells.
    Amaral I; Silva C; Correia-Branco A; Martel F
    Biomed Pharmacother; 2018 Jun; 102():94-101. PubMed ID: 29550639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of metformin on MDA-MB-231 breast cancer cells in a monolayer culture and in tumor spheroids as a function of nutrient concentrations.
    Bizjak M; Malavašič P; Pirkmajer S; Pavlin M
    Biochem Biophys Res Commun; 2019 Jul; 515(2):296-302. PubMed ID: 31146913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.
    Zordoky BN; Bark D; Soltys CL; Sung MM; Dyck JR
    Biochim Biophys Acta; 2014 Jun; 1840(6):1943-57. PubMed ID: 24462945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of 2-deoxy-D-glucose on the target metabolome profile of a human endometrial cancer cell line.
    Urakami K; Zangiacomi V; Yamaguchi K; Kusuhara M
    Biomed Res; 2013; 34(5):221-9. PubMed ID: 24190234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
    Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
    Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
    Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models.
    Cheong JH; Park ES; Liang J; Dennison JB; Tsavachidou D; Nguyen-Charles C; Wa Cheng K; Hall H; Zhang D; Lu Y; Ravoori M; Kundra V; Ajani J; Lee JS; Ki Hong W; Mills GB
    Mol Cancer Ther; 2011 Dec; 10(12):2350-62. PubMed ID: 21992792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells.
    Rajh M; Dolinar K; Miš K; Pavlin M; Pirkmajer S
    PLoS One; 2016; 11(5):e0154747. PubMed ID: 27135408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of metformin and 2-deoxyglucose inhibits autophagy and induces AMPK-dependent apoptosis in prostate cancer cells.
    Ben Sahra I; Tanti JF; Bost F
    Autophagy; 2010 Jul; 6(5):670-1. PubMed ID: 20559023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose promotes breast cancer aggression and reduces metformin efficacy.
    Wahdan-Alaswad R; Fan Z; Edgerton SM; Liu B; Deng XS; Arnadottir SS; Richer JK; Anderson SM; Thor AD
    Cell Cycle; 2013 Dec; 12(24):3759-69. PubMed ID: 24107633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration.
    He J; Wang K; Zheng N; Qiu Y; Xie G; Su M; Jia W; Li H
    Sci Rep; 2015 Nov; 5():17423. PubMed ID: 26616174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer.
    Mert I; Chhina J; Allo G; Dai J; Seward S; Carey MS; Llaurado M; Giri S; Rattan R; Munkarah AR
    Gynecol Oncol; 2017 Aug; 146(2):319-326. PubMed ID: 28545687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic Approaches to Investigate the Effect of Metformin: An Overview.
    Kim HW
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.
    Ben Sahra I; Laurent K; Giuliano S; Larbret F; Ponzio G; Gounon P; Le Marchand-Brustel Y; Giorgetti-Peraldi S; Cormont M; Bertolotto C; Deckert M; Auberger P; Tanti JF; Bost F
    Cancer Res; 2010 Mar; 70(6):2465-75. PubMed ID: 20215500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.